Issues › Biosecurity Research Oversight
Biosecurity Research Oversight
6 statements about Biosecurity Research Oversight from 6 members since Jan 3, 2025.
Statements about Biosecurity Research Oversight, last 12 weeks
DemRep● = 1 statement
Statements per week mentioning Biosecurity Research Oversight, all members, split by party. Democrats stacked first, Republicans after, four to a row. Hover a dot for the member and headline; click a dot to search for that headline. Click a week to set the dates below. Aug 17, 2026 – Nov 7, 2026.
Most active on Biosecurity Research Oversight · Aug 17 – Nov 7
Click a name to open their profile. Count is statements, not channel copies.
3 statements
Newest first-
Chaired hearing on U.S. biotechnology leadership and competition with China.
“American biotechnology has long been one of our nation’s greatest strategic assets, but that leadership is no longer guaranteed”
-
Pfluger, Houlahan Introduce the Biosecurity Modernization and Innovation Act
Introduced bipartisan bill to regulate DNA synthesis technology and prevent dangerous pathogen creation.
“Biotechnology is one of America's greatest strategic advantages. Right now, there's a dangerous gap between how fast this technology is moving and the safeguards we have in place to keep it out of the wrong hands.”
-
Senator Marshall: Congress Must Permanently End Gain-of-Function Research
Urged Senate to permanently ban taxpayer funding for viral gain-of-function research.
“We have developed a foolproof system for safely conducting this type of research.”
Sources: members’ press releases from their official websites (since the 119th Congress began (Jan 3, 2025)) and the Congressional Record (since Aug 2026). Statements are tagged to Biosecurity Research Oversight by AI reading of the full text. Quotes are shown only when they match the archived source text word for word.